Drug intelligence / Profile preview

HSF1 siRNA

Development stage
Preclinical
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intravenous, Intratumoral, Intraperitoneal, Intranasal
01

Overview

HSF1 siRNA is a small interfering RNA (siRNA) designed to silence the expression of Heat Shock Factor 1 (HSF1), a master transcriptional regulator of the heat shock response. HSF1 coordinates the expression of various molecular chaperones, such as HSP70, which are essential for maintaining protein homeostasis and protecting cells against stressors like oxidative stress, inflammation, and protein aggregation. In research contexts, HSF1 siRNA is utilized as a tool to investigate the role of the HSF1/HSP70 pathway in neuroprotection and disease pathogenesis. For instance, in in vitro models of Parkinson's disease, HSF1 siRNA is used to demonstrate how the downregulation of this factor can attenuate the protective effects of antioxidants like melatonin against neurotoxic insults. While primarily used as a research reagent, HSF1 inhibition is also a subject of interest in oncology, where HSF1 often supports the survival and proteostasis of malignant cells.

Other names
heat shock factor 1 siRNAsiRNA-HSF1siRNA-HSF-1siRNA-HSF 1siHSF1siHSF-1siHSF 1HSF1-siRNAHSF-1-siRNAHSF 1-siRNA
02

Targets

HSF1 (Heat shock factor protein 1)

Beyond the preview

Go deeper on HSF1 siRNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HSF1 siRNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call